Additionally, combined treatment of HPV16-positive HNSCC [336] and NSCLC [329] cells with MB and Bcl-2 inhibitor ABT-737 induced apoptosis and overcame resistance to single agent treatment. Here, BCL2 is linked to non-small cell lung carcinoma.